ABO blood group system

Milliman analysis: Competitive pricing rate for pension risk transfer costs increases to 100.0% in June

Retrieved on: 
Friday, July 23, 2021
Academic disciplines, Annuities, Finance, Money, Actuarial science, Pension buyout, Milliman, Pension, Life annuity, Insurance

SEATTLE, July 23, 2021 /PRNewswire/ --Milliman, Inc., a premier global consulting and actuarial firm, today announced the latest results of its Milliman Pension Buyout Index (MPBI).

Key Points: 
  • SEATTLE, July 23, 2021 /PRNewswire/ --Milliman, Inc., a premier global consulting and actuarial firm, today announced the latest results of its Milliman Pension Buyout Index (MPBI).
  • As the Pension Risk Transfer (PRT) market continues to grow, it has become increasingly important to monitor the annuity market for plan sponsors that are considering transferring retiree pension obligations to an insurer.
  • During June, the average estimated cost to transfer retiree pension risk to an insurer rose, from 102.0% of a plan's total liabilities to 102.4% of those liabilities.
  • Meanwhile annuity purchase costs reflecting competition amongst insurers also increased, from 99.7% in May to 100.0% in June.

AB Science announces a voluntary hold in the clinical studies of masitinib worldwide

Retrieved on: 
Tuesday, June 1, 2021
Branches of biology, Blood, Health sciences, Masitinib, Clinical pharmacology, ABO blood group system, Clinical trial, Euronext

AB Science SA (Euronext - FR0010557264 - AB) announced today that it has taken the decision to suspend inclusions and treatment initiation in its clinical studies with masitinib worldwide.

Key Points: 
  • AB Science SA (Euronext - FR0010557264 - AB) announced today that it has taken the decision to suspend inclusions and treatment initiation in its clinical studies with masitinib worldwide.
  • To this end, AB Science has filed or will file without delay a request for a temporary study hold in all countries where these studies are ongoing.
  • AB Science has identified a potential risk of ischemic heart disease with masitinib.
  • AB Science is working in full collaboration with the regulatory authorities in order to resume patient enrollment in these studies.

New Study Contributes to Evidence for Potential Association between Blood Group A and Risk of COVID-19 Infection

Retrieved on: 
Wednesday, March 3, 2021
Branches of biology, Blood, Medical specialties, Transfusion medicine, Hematology, Red blood cell, ABO blood group system, Blood compatibility testing

The team assessed synthetic blood group antigens on respiratory and red blood cells found in blood group A, B, and O individuals, and analyzed how the SARS-CoV-2 RBD interacted with each unique blood type.

Key Points: 
  • The team assessed synthetic blood group antigens on respiratory and red blood cells found in blood group A, B, and O individuals, and analyzed how the SARS-CoV-2 RBD interacted with each unique blood type.
  • They discovered that the RBD had a strong preference for binding to blood group A found on respiratory cells.
  • It did not display a preference for blood group A red blood cells, or other blood groups found on respiratory or red cells.
  • The capacity of the RBD to preferentially recognize and attach to the blood type A antigen found in the lungs of blood type A individuals may provide insight into the potential link between blood group A and COVID-19 infection.

Blood Group Typing Market Research Report by Techniques, by Test Type, by Product, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

Retrieved on: 
Monday, November 2, 2020
Medical specialties, Blood, Branches of biology, Transfusion medicine, Hematology, Blood type, Human leukocyte antigen, Cross-matching, ABO blood group system, Tissue typing, Blood transfusion

Based on Test Type, the Blood Group Typing Market studied across ABO Blood Tests, Antibody Screening, Antigen Typing, Cross-matching Series, and Human Leukocyte Antigen (HLA) Typing.

Key Points: 
  • Based on Test Type, the Blood Group Typing Market studied across ABO Blood Tests, Antibody Screening, Antigen Typing, Cross-matching Series, and Human Leukocyte Antigen (HLA) Typing.
  • Based on End User, the Blood Group Typing Market studied across Blood Banks, Clinical Laboratories, and Hospitals.
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Blood Group Typing Market during the forecast period?
  • What are the modes and strategic moves considered suitable for entering the Global Blood Group Typing Market?

Studies Offer New Evidence for Possible Link Between Blood Type and COVID-19 Susceptibility and Severity

Retrieved on: 
Wednesday, October 14, 2020
Medical specialties, Branches of biology, Blood, Hematology, Transfusion medicine, Occupational safety and health, Coronavirus disease, Zoonoses, ABO blood group system, Face masks during the COVID-19 pandemic

The potential role of blood type in predicting risk and complications of COVID-19 infection has emerged as an important scientific question.

Key Points: 
  • The potential role of blood type in predicting risk and complications of COVID-19 infection has emerged as an important scientific question.
  • Blood type O may offer some protection against COVID-19 infection, according to a retrospective study .
  • Among the COVID-19 positive, they found fewer people with blood type O and more people with A, B, and AB types.
  • "The unique part of our study is our focus on the severity effect of blood type on COVID-19.

FDA approves new DNA-based test to determine blood compatibility

Retrieved on: 
Thursday, October 11, 2018
Blood, Transfusion medicine, Medicine, Hematology, Anatomy, Blood transfusion, ABO blood group system, Assay, Blood type, Cross-matching

SILVER SPRING, Md., Oct. 11, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration today approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility.

Key Points: 
  • SILVER SPRING, Md., Oct. 11, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration today approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility.
  • The assay can be used to determine blood donor and patient non-ABO red blood cell (RBC) types.
  • "The approval of the ID CORE XT Test can streamline blood compatibility testing and provides an additional alternative to testing blood with antisera," said Peter Marks, M.D., Ph.D., M.D., director of the FDA's Center for Biologics Evaluation and Research.
  • Human blood can be classified into different groups based on the antigens on the surfaces of red blood cells.